These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 24626561

  • 1. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
    Lee KH, Choi EY, Koh SA, Kim MK, Jang BI, Kim SW, Kim JR.
    Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells.
    Lee KH, Koh SA, Kim JR.
    Oncol Res; 2013 May; 20(9):393-402. PubMed ID: 23924923
    [Abstract] [Full Text] [Related]

  • 3. Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.
    Okusa Y, Ichikura T, Mochizuki H, Shinomiya N.
    Int J Oncol; 2000 Nov; 17(5):1001-5. PubMed ID: 11029504
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB, Tang B, Wang GZ, Xie R, Hu CJ, Wang SM, Wu YY, Liu E, Xie X, Yang SM.
    Cancer Lett; 2015 May 28; 361(1):57-66. PubMed ID: 25727320
    [Abstract] [Full Text] [Related]

  • 5. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
    Cheng CY, Hsieh HL, Sun CC, Lin CC, Luo SF, Yang CM.
    J Cell Physiol; 2009 Apr 28; 219(1):183-93. PubMed ID: 19097143
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 7. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
    Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.
    Exp Mol Med; 2006 Feb 28; 38(1):27-35. PubMed ID: 16520550
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.
    Lee KH, Choi EY, Koh SA, Kim MK, Kim KO, Lee SH, Jang BI, Kim SW, Kim SW, Song SK, Choi JH, Kim JR.
    Exp Mol Med; 2011 Sep 30; 43(9):501-9. PubMed ID: 21734448
    [Abstract] [Full Text] [Related]

  • 9. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul 30; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 10. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 11. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
    Mori Y, Akita K, Tanida S, Ishida A, Toda M, Inoue M, Yashiro M, Sawada T, Hirakawa K, Nakada H.
    J Biol Chem; 2014 Dec 19; 289(51):35193-204. PubMed ID: 25371209
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [Abstract] [Full Text] [Related]

  • 13. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
    Hall CL, Tsan R, Mugnai G, Mazar A, Radinsky R, Pettaway CA.
    Prostate; 2004 May 01; 59(2):167-76. PubMed ID: 15042617
    [Abstract] [Full Text] [Related]

  • 14. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 May 01; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 15. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.
    Lee KH, Kim SW, Kim JR.
    J Exp Clin Cancer Res; 2009 Jun 04; 28(1):73. PubMed ID: 19497102
    [Abstract] [Full Text] [Related]

  • 16. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.
    Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645
    [Abstract] [Full Text] [Related]

  • 17. [Epidermal growth factor-mediated NF-kappaB activation promotes uPA expression and invasiveness in pancreatic cancer cells].
    Zhang H, Liu XF, Li YJ, Zhou JP, Kong FM, Dong M.
    Zhonghua Zhong Liu Za Zhi; 2007 Dec 01; 29(12):909-12. PubMed ID: 18478929
    [Abstract] [Full Text] [Related]

  • 18. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J, Kou YB, Zhu JS, Chen WX, Li S.
    Int J Oncol; 2014 Apr 01; 44(4):1268-76. PubMed ID: 24481712
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
    Jin H, Pan Y, He L, Zhai H, Li X, Zhao L, Sun L, Liu J, Hong L, Song J, Xie H, Gao J, Han S, Li Y, Fan D.
    Mol Cancer Res; 2007 May 01; 5(5):423-33. PubMed ID: 17510309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.